Multicenter Study of Chloroprocaine Versus Ropivacaine for Epidural Labor Analgesia

Trial statusNot yet recruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexFemale
Age20+
SponsorWomen's Hospital School Of Medicine Zhejiang University

About this trial

Women requiring epidural labor analgesia were randomized into two groups, one with the local anesthetic chloroprocaine and the other with ropivacaine. The primary outcome was to observe the analgesic scores of the two groups of drugs as well as adverse reactions.

Eligibility criteria

Qualifiers

Primigravid women with full-term pregnancies scheduled for labor analgesia

Determination of labor onset to cervical dilatation ≤ 5cm;

Visual analogue scale (VAS) pain score during contractions >50 mm (0 mm = no pain at all, 100 mm = most intense pain);

Age ≥20 years;

Disqualifiers

Twin or multiple pregnancies

Hypertension

Severe cardiopulmonary and hepatic or renal disease

Severe pregnancy comorbidities such as preeclampsia, eclampsia, HELLP syndrome, placenta praevia, placental abruption, etc.

Trial design

Treatments tested in this trial

  • Chloroprocaine

Treatment groups

356 Participants
are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators

Women's Hospital School Of Medicine Zhejiang University

Lead sponsor

Beijing Obstetrics and Gynecology Hospital

Collaborator

International Peace Maternity and Child Health Hospital

Collaborator

Nanjing Medical University

Collaborator

Anhui Women and Children's Medical Center

Collaborator

Jiaxing Maternity and Child Health Care Hospital

Collaborator

Gansu Maternal and Child Health Center

Collaborator

Urumqi Maternal and Child Health Center

Collaborator

Shengjing Hospital

Collaborator

Zhongnan Hospital

Collaborator

Second Affiliated Hospital of Wenzhou Medical University

Collaborator

Second Hospital of Jilin University

Collaborator